Samfara Makes Debut Buyout With Danish API Maker Chr. Olesen Synthesis
London-based Samfara has made its first investment, backing a Danish maker of controlled-substance APIs. How the buyout works and what to watch.
Samfara Makes Debut Buyout With Danish API Maker Chr. Olesen Synthesis
London-based Samfara has made its first investment, backing a Danish maker of controlled-substance APIs. How the buyout works and what to watch.
AstraZeneca, Daiichi Sankyo and Summit Build a Cost-Sharing Cancer Trial Pact Around Datroway and Ivonescimab
Three companies, three assets, shared costs: how the AstraZeneca, Daiichi Sankyo and Summit trial pact works and what it signals for oncology deals.
TIL Healthcare Pharma Plant Blast in Andhra Pradesh’s Sri City Leaves Workers Dead and Injured
A boiler explosion at the TIL Healthcare plant in Sri City, Andhra Pradesh killed five workers and injured over 10 on 3 October; cause is under probe.
Roche Launches Newborn Screening Test for SMA, SCID, SCD
Roche launches a CE-marked newborn screening test that detects SMA, SCID and sickle cell disease in one assay on LightCycler systems; not sold in the US.
Rakovina and Celvion Partner on AI-Driven Cancer Therapy
Rakovina Celvion partnership uses the EMphora AI platform and real-world clinical data to guide ATR inhibitor development; no financial terms disclosed.
Ensera Launches Alliance Network for Combination Products
Ensera alliance network links SHL Medical, Stevanato, Ypsomed, Argonaut and American Injectables to speed drug-device combination product supply.
Artificial Organs Market to Top $63 Billion by 2035
Artificial organs market size was $28.71 billion in 2025 and is projected to top $63.31 billion by 2035 at an 8.2% CAGR, led by North America.
AI in Neurosurgery Market to Reach $11.3 Billion by 2035
AI in neurosurgery market size was $850 million in 2025 and is forecast to hit $11.3 billion by 2035 at a 29.5% CAGR, led by North America and software.
AI in Healthcare Market to Reach $1.14 Trillion by 2035 at 39.1% CAGR
The AI in healthcare market was valued at $41.84 billion in 2025 and is projected to top $1.13 trillion by 2035, growing at a 39.1% CAGR led by North America.
